CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas

Breast Cancer Research and Treatment

Volumn 44, Issue 3, 1997, Pages 261-268

  Guriec, Nathalie ^a,d   Gairard, Béatrice ^b   Marcellin, Luc ^c   Wilk, Astrid ^b   Caldéroli, Hubert ^b   Renaud, Robert ^b   Bergerat, Jean Pierre ^b   Oberling, Francis ^a  

^a Inst de Rech en Hématologie   (France)

^b Department of Gynaecology ^*  (France)

^c HÔPITAL DE HAUTEPIERRE   (France)

^d GUY S HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; CD44v6; Metastasis; Patients N0M0

Indexed keywords

HERMES ANTIGEN;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ARTICLE; BREAST CANCER; BREAST FIBROADENOMA; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC VALUE; EXON; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; EXONS; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMANS; HYPERTROPHY; MIDDLE AGED; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; PROGNOSIS;

EID: 0030849265     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005717519931     Document Type: Article

References (29)

1. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seeb B: CD44 is the principal cell surface receptor for hyaluronate. Cell 61: 1303-1313, 1990
2. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 11: 359-377, 1957
3. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Analytical Biochem 162: 156-159, 1987
4. Cooper DL, Dougherty GJ: To metastasize or not? Selection of CD44 splice sites. Nature Med 1: 635-637, 1995
5. Dall P, Heider KH, Sinn HP, Skroch-Angel P, Adolf G, Kaufmann M, Herrlich P, Ponta H: Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int J Cancer 60: 471-477, 1995
6. Dougherty GJ, Cooper DL, Memory JF, Chiu RK: Ligand binding specificity of alternatively spliced CD44 isoforms. J Biol Chem 269: 9074-9078, 1994
7. Drool A, Dougherty ST, Chiu RK, Dirko JF, McBride WH, Cooper DL, Dougherty GJ: Adhesive interactions between alternatively spliced CD44 isoforms. J Biol Chem 270: 11567-11573, 1995
8. Fox SB, Fawcett J, Jackson DG, Collins I, Gatter KC, Harris AL, Gearing A, Simmons DL: Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 54: 4539-4546, 1994
9. Fox SB, Gatter KC, Jackson DG, Screaton GR, Bell MV, Bell JI, Harris AL, Simmons D, Fawcett J: CD44 and cancer screening. Lancet 342: 548-549, 1993
10. Friederichs K, Franke F, Lisboa BJ, Kügler G, Gille I, Terpe HJ, Hölzel F, Maass H, Günthert U: CD44 Isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Res 55: 5424-5433, 1995
11. Günthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haudbmann I, Matzku S, Wenzel A, Ponta H, Herrlich P: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13-24, 1991
12. Hartmann WH, Uzello L, Sobin LH, Stalsberg H (eds): Histological Typing of Breast Tumors, Ed. 2, pp 15-25. Geneva, Switzerland: World Health Organization, 1981
13. Iida N, Bourguignon LW: New CD44 splice variants associated with human breast cancers. J Cell Phys 162: 127-133, 1995
14. International Union Against Cancer (UICC): TNM Classification of Malignant Tumors, Ed. 4, pp 748-759. Berlin-Heidelberg, Germany: Springer-Verlag, 1987
15. Jalkanen S, Bargatze RF, Herron LR, Butcher EC: A lymphoid cell surface protein involved in endothelial cell recognition and lymphocyte homing in man. Eur J Immunol 16: 1195-1202, 1986
16. Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Statis Assoc 53: 457-481, 1958
17. Kaufmann M, Heider KH, Sinn HP, Von Minckwitz G, Ponta H, Herrlich P: CD44 Variant exon epitopes in primary breast cancer and length of survival. Lancet 345: 615-619, 1995
18. Liotta LA, Stetler-Stevenson WG: Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51: 5054s-5059s, 1991
19. Matsumara Y, Tarin D: Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340: 1053-1058, 1992
20. Milstone LM, Hough-Monroe L, Kugelman LC, Bender JR, Haggerty JG: Epican, a heparan/chondroitin sulfate proteoglycan form of CD44, mediates cell-cell adhesion. J Cell Sci 107: 3183-3190, 1994
21. Peto R, Pike MC, Armitage P: Design and analysis of randomized clinical trials requiring prolonged observations of each patients. Br J Cancer 35: 1-39, 1977
22. Rio MC, Bellocq JP, Gairard B, Rasmussen UB, Krust A, Koehl C, Calderoli H, Schiff V, Renaud R, Chambon P: Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the oestrogen and progesterone receptors and the oncogene ERBB2. Proc Natl Acad Sci USA 84: 9243-9247, 1987
23. Rodriguez C, Monges G, Rouanet P, Dutrillaux B, Lefrançois D, Theillet C: CD44 expression patterns in breast and colon tumors: A PCR-based study of splice variants. Int J Cancer 64: 347-354, 1995
24. Ruoslahti E: Control of cell motility and tumor invasion by extracellular matrix interactions. Br J Cancer 66: 239-242, 1992
25. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89: 12160-12164, 1992
26. Seiter S, Arch R, Reber S, Komitowski D, Hofman M, Ponta H, Herrlich H, Matzku S, Zöller M: Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 177: 443-455, 1993
27. Stamenkovic I, Aruffo A, Amiot B, Seed B: The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-binding cells. EMBO J 10: 343-348, 1991
28. Wald N, Frost C, Cuckle H: Breast cancer screening, the current position. Br Med J 302: 845-846, 1991
29. Zetter BR: Adhesion molecules in tumor metastasis. Semin Cancer Biol 4: 219-229, 1993